MarketInOut Stock Screener Log In | Sign Up
 

Fortress Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 07/10/2026 16:00
Fortress Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization109.29 mln
Float23.09 mln
Earnings Date08/17/2026

EPS

3.53
Solid

P / E

0.93
Anomalous

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-5.09
Highly reliable

Relative Strength

86 / 100
Strongly outperforming

Debt / Equity

0.33
Low leverage

Business Description

Fortress Biotech is a Florida-based pharmaceutical company that develops and sells a wide range of medical treatments, with a particular focus on skin conditions such as acne, rosacea, and fungal infections. Beyond dermatology, the company is advancing treatments for serious illnesses including cancer, rare genetic disorders, and post-surgical pain. It also has a growing pipeline of early and pre-clinical therapies spanning areas such as gout, brain tumors, and gene therapy. Founded in 2006 and originally known as Coronado Biosciences, the company works across multiple stages of drug development, from early research through to commercial sales.

Key Fundamentals

EPS3.53
P/E0.93
ROE191
RPS2.03
ROIC-82.20
ROA60.17
EBITDA, mln146
EV / EBITDA-0.49
EV / EBIT-0.50
Revenue, mln66.16
EV / Revenue-1.07

Financial Strength

Altman Z-Score0.04
Piotroski F-Score 8 / 9
Beneish M-Score-5.09
Short Ratio10.74
Short % of Float20.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.55% 95 / 100   
1 Month 12.63% 87 / 100   
2 Months 33.6% 88 / 100   
6 Months -22.72% 22 / 100   
1 Year 65.83% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us